Gambardella, V., Navarro, A., Jain, P., López-Picazo, J. M., Hinojal, G. F., Zugazagoitia, J., Miguel, M. J. D., Gadgeel, S. M., Bhatti, S. A., Rocha, P., Vilalta-Lacarra, A., Imedio, E. R., Micallef, S., Wessen, J., Dozio, V., Franzen, R. F., Bellon, A., Paz-Ares, L. G. (2025). Debio 0123, a highly selective WEE1 inhibitor, in combination with carboplatin (C) and etoposide (E), in patients (pts) with recurrent small cell lung cancer (SCLC): Determination of recommended dose (RD) from a phase 1 escalation.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.8098